DE3784835T2 - Chinoxalinon-derivate. - Google Patents

Chinoxalinon-derivate.

Info

Publication number
DE3784835T2
DE3784835T2 DE8787309160T DE3784835T DE3784835T2 DE 3784835 T2 DE3784835 T2 DE 3784835T2 DE 8787309160 T DE8787309160 T DE 8787309160T DE 3784835 T DE3784835 T DE 3784835T DE 3784835 T2 DE3784835 T2 DE 3784835T2
Authority
DE
Germany
Prior art keywords
chinoxalinone
derivatives
quinoxalinones
quinoxalinone
alkoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787309160T
Other languages
English (en)
Other versions
DE3784835D1 (de
Inventor
Reinhard Sarges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE3784835D1 publication Critical patent/DE3784835D1/de
Application granted granted Critical
Publication of DE3784835T2 publication Critical patent/DE3784835T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8787309160T 1986-10-30 1987-10-16 Chinoxalinon-derivate. Expired - Fee Related DE3784835T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1986/002335 WO1992005160A1 (en) 1986-10-30 1986-10-30 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Publications (2)

Publication Number Publication Date
DE3784835D1 DE3784835D1 (de) 1993-04-22
DE3784835T2 true DE3784835T2 (de) 1993-06-24

Family

ID=22195697

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309160T Expired - Fee Related DE3784835T2 (de) 1986-10-30 1987-10-16 Chinoxalinon-derivate.

Country Status (11)

Country Link
US (1) US4940708A (de)
EP (1) EP0266102B1 (de)
JP (1) JPS63295566A (de)
AT (1) ATE86985T1 (de)
DE (1) DE3784835T2 (de)
DK (1) DK561487A (de)
ES (1) ES2046206T3 (de)
GR (1) GR3007402T3 (de)
IE (1) IE68851B1 (de)
PT (1) PT85998B (de)
WO (1) WO1992005160A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
US6369057B1 (en) 1991-04-15 2002-04-09 Aventis Pharma Deutschland Gmbh Quinoxalines, processes for their preparation and their use
EP0509398B1 (de) * 1991-04-15 2001-09-19 Aventis Pharma Deutschland GmbH Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
AU2006284403A1 (en) * 2005-08-26 2007-03-01 Methylgene Inc. Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
EP3480217A1 (de) 2008-04-30 2019-05-08 Xyleco, Inc. Verarbeitung von biomasse
US8212087B2 (en) 2008-04-30 2012-07-03 Xyleco, Inc. Processing biomass
US8236535B2 (en) 2008-04-30 2012-08-07 Xyleco, Inc. Processing biomass
US7867358B2 (en) 2008-04-30 2011-01-11 Xyleco, Inc. Paper products and methods and systems for manufacturing such products
KR20180126092A (ko) 2008-10-28 2018-11-26 질레코 인코포레이티드 탄화수소-함유 재료의 처리방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
JPS5559314A (en) * 1978-10-27 1980-05-02 Sony Corp Magnetic scale signal detector
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts

Also Published As

Publication number Publication date
DK561487D0 (da) 1987-10-27
PT85998A (en) 1987-11-01
DE3784835D1 (de) 1993-04-22
JPS63295566A (ja) 1988-12-01
GR3007402T3 (de) 1993-07-30
WO1992005160A1 (en) 1992-04-02
EP0266102A2 (de) 1988-05-04
ES2046206T3 (es) 1994-02-01
IE68851B1 (en) 1996-07-24
PT85998B (pt) 1990-08-31
IE872877L (en) 1988-04-28
EP0266102B1 (de) 1993-03-17
ATE86985T1 (de) 1993-04-15
JPH0536436B2 (de) 1993-05-31
DK561487A (da) 1988-08-08
US4940708A (en) 1990-07-10
EP0266102A3 (en) 1989-11-23

Similar Documents

Publication Publication Date Title
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
EE03139B1 (et) Piperasiiniderivaadid, nende kasutamine ja farmatseutiline kompositsioon
NO905572D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
NL960019I1 (nl) Moforlino-ethylester van mycofenolzuur en derivaten ervan, de bereiding ervan en hun toepassing in farmaceutische samenstellingen.
YU46087B (sh) Postupak za dobijanje analoga rebekamicina
KR920002608A (ko) 라파마이신 유도체
ES2082805T3 (es) Derivados de tiazol, procedimientos para su produccion y composiciones farmaceuticas que comprenden los mismos.
DE3784835D1 (de) Chinoxalinon-derivate.
AP1555A (en) Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
ES2103931T3 (es) Imidazoacridinas y su uso antineoplasico.
ATE121743T1 (de) Pyridazinon-derivate.
ES2065994T3 (es) Beta-dicetonas substituidas.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
KR910000637A (ko) 피롤 유도체, 이의 제조 방법 및 약제학적 활성화합물로서의 이의 용도
ES8704881A1 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
BE895712A (fr) Derives de benzo-1,3-thiazine-1,1-dixoyde, leur preparation et leur utilisation
DE3578168D1 (de) Aminoalkylnaphthalen-derivate mit pharmakologischer wirkung.
ES8704495A1 (es) Un procedimiento para la preparacion de un derivado tetraci-clico de espirohidantoina biologicamente activo.
DE3766028D1 (de) 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester.
ES2070873T3 (es) Carbinoloimidazoles antiinflamatorios.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee